TRACON Pharmaceuticals (aka TRACON PHARMA)

1-TRC105 is a Phase 2 monoclonal antibody that binds CD105 (endoglin), a membrane receptor on endothelial cells that is required for angiogenesis; it...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of TRACON Pharmaceuticals (aka TRACON PHARMA) plus 5119 other startups.

Start Free 7 Day Trial Now

Learn More About TRACON Pharmaceuticals (aka TRACON PHARMA)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients